(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202312 | 202212 | % Var | 202312 | 202212 | % Var | 202303 | 202203 | % Var | |
| Sales | 26920.30 | 23609.10 | 14.03 | 77516.10 | 60507.70 | 28.11 | 127922.80 | 112871.40 | 13.33 |
| Other Income | 3311.30 | 780.10 | 324.47 | 4930.90 | 1713.20 | 187.82 | 4337.60 | 6709.90 | -35.36 |
| PBIDT | 8128.20 | 5222.40 | 55.64 | 19423.40 | 10960.40 | 77.21 | 21646.80 | 21443.90 | 0.95 |
| Interest | 612.50 | 252.60 | 142.48 | 1295.30 | 428.00 | 202.64 | 1149.80 | 169.40 | 578.75 |
| PBDT | 7515.70 | 4969.80 | 51.23 | 18128.10 | 10532.40 | 72.12 | 20497.00 | 20527.40 | -0.15 |
| Depreciation | 643.50 | 598.70 | 7.48 | 1897.70 | 1765.80 | 7.47 | 4353.50 | 4152.60 | 4.84 |
| PBT | 6872.20 | 4371.10 | 57.22 | 16230.40 | 8766.60 | 85.14 | 16143.50 | 16374.80 | -1.41 |
| TAX | 634.40 | 1141.70 | -44.43 | 3016.10 | 2336.40 | 29.09 | 3839.40 | 1827.70 | 110.07 |
| Deferred Tax | -735.10 | -91.90 | 699.89 | -888.10 | -225.70 | 293.49 | -230.80 | -1969.30 | -88.28 |
| PAT | 6237.80 | 3229.40 | 93.16 | 13214.30 | 6430.20 | 105.50 | 12304.10 | 14547.10 | -15.42 |
| Equity | 585.90 | 585.90 | 0.00 | 585.90 | 585.90 | 0.00 | 585.90 | 585.90 | 0.00 |
| PBIDTM(%) | 30.19 | 22.12 | 36.50 | 25.06 | 18.11 | 38.33 | 16.92 | 19.00 | -10.93 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: